New Year Address of Beroni Group

About
R&D
Core Businesses
Products
- By Beroni China
- By Medicine Plus
Investors
News
Contact
English

Menu

Home>
2018>
December>
29>
2018>
New Year Address of Beroni Group

New Year Address of Beroni Group

admin
2018-12-29
2018

You Might Also Like

Australian MEDTECH Mission to Singapore

2018-10-08

H. E. Yukio Hatoyama, Former Prime Minister of Japan attending The Second Precision Medicine & Medical Care and Aging International Forum

2018-12-21

The latest results of the ” Cancer New Drug PENAO” project are released!

2018-08-22

Search Article

Arrange by Year

2017 (11)
2018 (25)
2019 (16)

What’s New

Successful Conclusion to Beroni Group’s 2019 China-Japan Scientific and Technological Exchange Symposium
Tianjin Association of Science and Technology’s Visit to Beroni Group
Beroni Group Expands Into Strategic Relationship With Jinshui Science & Education Park In Zhengzhou, China
Beroni China has achieved the ISO14001:2015 Certification
Successful Conclusion to Beroni Group’s 2019 Scientific and Technological Strategy Symposium

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the U.S.A with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trail, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

About Beroni
Our History
Board of Directors
Management Team
Vision, Mission, and Values

New Year Address of Beroni Group

About

Core Businesses

Products

Copyrights© Beroni Group 2019 | All rights reserved |

津ICP备14003612号-2

website by chase e-Design